News headlines about Transcat (NASDAQ:TRNS) have been trending somewhat positive recently, according to Accern. The research firm identifies positive and negative press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Transcat earned a coverage optimism score of 0.12 on Accern’s scale. Accern also gave press coverage about the scientific and technical instruments company an impact score of 47.1038720781728 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Transcat (TRNS) traded up 1.1878% during mid-day trading on Tuesday, reaching $13.3062. 10,179 shares of the company traded hands. The stock has a market capitalization of $94.75 million, a PE ratio of 21.1210 and a beta of 0.34. Transcat has a 52-week low of $9.97 and a 52-week high of $14.05. The stock has a 50-day moving average of $12.39 and a 200 day moving average of $12.04.

Transcat (NASDAQ:TRNS) last issued its quarterly earnings results on Tuesday, July 25th. The scientific and technical instruments company reported $0.12 EPS for the quarter. Transcat had a net margin of 3.03% and a return on equity of 10.54%. The firm had revenue of $36.28 million during the quarter. Equities research analysts expect that Transcat will post $0.64 earnings per share for the current year.

In related news, Director Carl E. Sassano sold 7,500 shares of the company’s stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $13.02, for a total transaction of $97,650.00. Following the completion of the transaction, the director now owns 79,075 shares of the company’s stock, valued at $1,029,556.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders have purchased 2,081 shares of company stock valued at $24,924 in the last ninety days. 8.80% of the stock is currently owned by company insiders.

COPYRIGHT VIOLATION WARNING: “Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Transcat (TRNS) Stock Price” was first published by Daily Political and is the property of of Daily Political. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The correct version of this article can be accessed at https://www.dailypolitical.com/2017/08/08/somewhat-favorable-media-coverage-somewhat-unlikely-to-affect-transcat-trns-stock-price.html.

About Transcat

Transcat, Inc is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak).

Insider Buying and Selling by Quarter for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat Inc. and related companies with MarketBeat.com's FREE daily email newsletter.